The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 109.50
Ask: 110.50
Change: 1.00 (0.91%)
Spread: 1.00 (0.913%)
Open: 110.00
High: 112.00
Low: 109.50
Prev. Close: 109.50
MCB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of European Personal Care liquids

3 Jul 2018 07:00

RNS Number : 3461T
McBride PLC
03 July 2018
 

3 July 2018

 

McBride plc

 

Sale of European Personal Care liquids

 

McBride plc, the leading European manufacturer and supplier of Co-manufactured and Private Label products for the Household and Personal Care market, today announces that it has agreed to sell its European personal care liquids business to Royal Sanders Group for a cash consideration of £12.5m.

 

In its half year results of 22 February 2018, McBride announced plans to launch an accelerated transformation programme to return its Personal Care & Aerosols (PCA) division to break even within 18 months. Since February, the Group has announced proposals to close it UK aerosols operations at Hull. As a result of this action and the absorption of certain volumes into our French aerosols operation, the Group expects its ongoing aerosols operation to be at break-even profitability levels by July 2019.

 

As the next step in the PCA transformation programme, the Group today announces that it has agreed terms with Royal Sanders for the disposal of the Group's European Personal Care liquids activities, which comprises two manufacturing sites at Bradford, UK and Ieper, Belgium, which supply customers with a range of personal hygiene, haircare and oral care products.

 

The proposed transaction, which is subject to customary closing conditions, will comprise the disposal of the trade and assets of the Group's European personal care liquids business for a cash consideration of £12.5m (subject to any post-closing working capital adjustments), payable on completion. In the 12 months to June 2017 the business generated revenues of £58.8m and an EBITA loss of £1.9m. Gross assets at 31 December 2017 were £19.8m. For the 12 months to 30 June 2018, the business is expected to generate revenues of £56.0m and an EBITA loss of £2.8m. Proceeds of the sale will be used to pay down Group net debt and settle transaction costs. The transaction is expected to complete during the last quarter of 2018.

 

 

Rik De Vos, Group Chief Executive, commented;

 

"The agreement to sell our European Personal Care liquids activities follows a comprehensive review of the business and marks the final element in the transformation plan for our European PCA activities. The transaction enables the business to be developed as part of a dedicated personal care manufacturer of greater scale and positions McBride's European operations as a focused Household business with a clear strategy to deliver sustainable profitable growth." 

 

 

For further information please contact:

 

McBride plc

Rik De Vos, Chief Executive Officer

0161 203 7570

Chris Smith, Chief Financial Officer

0161 203 7570

FTI Consulting

020 3727 1017

Ed Bridges, Nick Hasell

 

Note: This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation which came into effect on 3 July 2016.

 

-Ends-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAAXAEEKPEAF
Date   Source Headline
22nd Apr 201612:00 pmRNSAppointment of Chairman Elect
5th Apr 20166:08 pmRNSHolding(s) in Company
8th Mar 20165:05 pmRNSHolding(s) in Company
1st Mar 20169:21 amRNSHolding(s) in Company
26th Feb 20161:31 pmRNSHolding(s) in Company
24th Feb 20167:00 amRNSHalf Yearly Report
17th Feb 20162:45 pmRNSHolding(s) in Company
12th Feb 20162:51 pmRNSHolding(s) in Company
3rd Feb 20162:05 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSTrading Update
22nd Dec 201511:36 amRNSHolding(s) in Company
14th Dec 20151:20 pmRNSDirector/PDMR Shareholding
14th Dec 201511:29 amRNSDirector/PDMR Shareholding
11th Dec 20151:27 pmRNSDirector/PDMR Shareholding
1st Dec 20155:25 pmRNSHolding(s) in Company
30th Nov 20152:33 pmRNSIssue of B Shares
25th Nov 20151:47 pmRNSHolding(s) in Company
21st Oct 201510:52 amRNSResult of AGM
20th Oct 20157:00 amRNSAGM Trading Update
19th Oct 20154:28 pmRNSHolding(s) in Company
2nd Oct 20153:25 pmRNSHolding(s) in Company
29th Sep 20158:59 amRNSHolding(s) in Company
18th Sep 20153:12 pmRNSAnnual Report and Accounts
18th Sep 20153:12 pmRNSTotal Voting Rights
17th Sep 20151:00 pmRNSDirector/PDMR Shareholding
17th Sep 20159:21 amRNSHolding(s) in Company
16th Sep 20153:14 pmRNSHolding(s) in Company
14th Sep 20158:29 amRNSDirector/PDMR Shareholding
11th Sep 20154:02 pmRNSDirector/PDMR Shareholding
11th Sep 20151:50 pmRNSHolding(s) in Company
9th Sep 20151:42 pmRNSHolding(s) in Company
8th Sep 20157:00 amRNSFinal Results
1st Sep 20151:10 pmRNSHolding(s) in Company
4th Aug 201510:17 amRNSHolding(s) in Company
15th Jul 201512:08 pmRNSHolding(s) in Company
14th Jul 20154:35 pmRNSHolding(s) in Company
7th Jul 20157:00 amRNSTrading Update
2nd Jun 201511:57 amRNSHolding(s) in Company
26th May 201511:24 amRNSDirector/PDMR Shareholding
20th May 20154:22 pmRNSHolding(s) in Company
20th May 20154:15 pmRNSDirector/PDMR Shareholding
12th May 20154:17 pmRNSHolding(s) in Company
22nd Apr 20154:36 pmRNSHolding(s) in Company
22nd Apr 20157:00 amRNSTrading Update
20th Apr 20154:45 pmRNSHolding(s) in Company
25th Feb 20158:48 amRNSHolding(s) in Company
20th Feb 20153:23 pmRNSDirector/PDMR Shareholding
11th Feb 20155:13 pmRNSHolding(s) in Company
5th Feb 20157:00 amRNSHalf Yearly Report
21st Jan 20159:05 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.